Literature DB >> 12093791

Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease.

Hieronim Jakubowski1.   

Abstract

Homocysteine is thought to be a non-protein amino acid. However, in vitro studies suggest that homocysteine is likely to be incorporated by indirect mechanisms into proteins in living organisms. Here I show that homocysteine is a protein amino acid in humans. Homocysteine bound by amide or peptide linkages (Hcy-N-protein) is present in human hemoglobin, serum albumin, and gamma-globulins. 1 molecule of homocysteine per 1000 or 1670 molecules of methionine was present in hemoglobin or albumin, respectively. Other proteins, such as low density lipoprotein, high density lipoprotein, transferrin, antitrypsin, and fibrinogen, contained lower amounts of Hcy-N-protein. In human plasma, levels of Hcy-N-protein represented from 0.3 to 23% of total homocysteine. Thus, Hcy-N-protein is a significant component of homocysteine metabolism in humans, possibly contributing to adverse effects of homocysteine on human cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093791     DOI: 10.1074/jbc.C200267200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.

Authors:  Kamila Borowczyk; Diana M Shih; Hieronim Jakubowski
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Effect of homocysteine thiolactone on structure and aggregation propensity of bovine pancreatic insulin.

Authors:  Shima Jalili; Reza Yousefi; Mohammad-Mehdi Papari; Ali Akbar Moosavi-Movahedi
Journal:  Protein J       Date:  2011-06       Impact factor: 2.371

3.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

Review 4.  Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.

Authors:  Nuria Carrillo-Carrasco; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

Review 5.  Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.

Authors:  Yi Fu; Xian Wang; Wei Kong
Journal:  Br J Pharmacol       Date:  2017-09-22       Impact factor: 8.739

6.  Characterization of N-homocysteinylated albumin adducts.

Authors:  Valeria Genoud; Mercedes Castañon; Ana María Lauricella; Irene Quintana
Journal:  Protein J       Date:  2014-02       Impact factor: 2.371

7.  Homocystamides promote free-radical and oxidative damage to proteins.

Authors:  Martha Sibrian-Vazquez; Jorge O Escobedo; Soojin Lim; George K Samoei; Robert M Strongin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-18       Impact factor: 11.205

8.  N- and S-homocysteinylation reduce the binding of human serum albumin to catechins.

Authors:  Angelo Zinellu; Salvatore Sotgia; Bastianina Scanu; Dionigia Arru; Annalisa Cossu; Anna Maria Posadino; Roberta Giordo; Arduino A Mangoni; Gianfranco Pintus; Ciriaco Carru
Journal:  Eur J Nutr       Date:  2015-12-10       Impact factor: 5.614

9.  Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?

Authors:  Utpal Sen; Suresh C Tyagi
Journal:  PPAR Res       Date:  2010-06-29       Impact factor: 4.964

10.  Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions.

Authors:  Aśok Antony; Ying-Sheng Tang; Rehana A Khan; Mangatt P Biju; Xiangli Xiao; Qing-Jun Li; Xin-Lai Sun; Hiremagalur N Jayaram; Sally P Stabler
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.